Study finds a screening byproduct, once thought to be clinically insignificant, is useful in predicting the likelihood of breast cancer in high-risk women
Dec. 4, 2014
| By Dr. Rachel Tompa / Fred Hutch News Service
A new study suggests that a feature of breast MRI imaging that previously was not known to have clinical implications can in fact help pinpoint the chances of developing breast cancer among those at high risk. That tool could lead to a more precise cancer-risk assessment.